#FutureReadyHealthcare
Latest Annual Report 2024-25
View Interactive Report
View PDF version
Company Overview

Indegene Limited is the tech-native, life sciences specialist orchestrating the path from commercialization strategy through activation. Trusted by 20 of the world’s top 20 biopharma companies across the value chain - from clinical and medical through commercial - Indegene helps life sciences leaders move at the speed of their ambition with #PractitionerLevelConfidence. Indegene’s difference comes from integrating deep domain knowledge, contextualized technology and operational excellence, built over 25 years. When bold life sciences leaders want to take breakthrough therapies to market faster, maximize impact, and create seamless experiences for patients and physicians, they count on Indegene.

Company Announcements
Read More
Latest Quarterly Reports
Q2
FY25-26
Press Release
Analyst Call Recording
Analyst Call Transcripts
Investor Presentation
Financial Results
Q2 FY25-26 Quarterly Results
Revenue

₹ 8,042 Mn

YoY Revenue Growth

17.1%

PAT

₹ 1,021 Mn

YoY PAT Growth

11.3%

Clients with $1 Million+ Revenue

40

Total Employees

5,245

Healthcare Expertise

26.3%

Women Employees

46.6%

Corporate Governance
Corporate Governance Policies Quarterly Compliance Report Other Documents CSR at Indegene Committees of the Board of Directors
Quick Links
Key Facts
Key Facts
Financial Information
Financial Information
Share Information
Share Information
Contact IR
Contact IR
Regulation 46(2)
Corporate Governance
Composition of various committees of Board of Directors Disclosure to Stock Exchanges
Statement of deviations or variations Annual Returns
Policies and Terms
Terms and conditions of appointment of independent directors Code of conduct of board of directors and senior management personnel Whistle Blower policy Criteria of making payments to non-executive directors
Policy on dealing with related party transactions Policy for determining 'material' subsidiaries Details of familiarization programmes imparted to independent directors Policy for determination of materiality of events or information Dividend Distribution Policy
Investor Kit
Shareholding Pattern Investor Contacts For the purpose of determination of materiality of events or information, contact details of KMP
Intimation of Schedule of Earnings Call under Regulation 30(6) of the SEBI Analyst Audio Recording Analyst Call Transcript
Newspaper Publication
Advertisement as per 47(1)